MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 21 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,528,000 | -8.4% | 200,000 | 0.0% | 0.01% | -13.3% |
| Q3 2015 | $1,668,000 | -28.1% | 200,000 | 0.0% | 0.02% | -25.0% |
| Q2 2015 | $2,320,000 | +29.0% | 200,000 | 0.0% | 0.02% | +33.3% |
| Q1 2015 | $1,798,000 | -16.8% | 200,000 | -2.2% | 0.02% | -31.8% |
| Q4 2014 | $2,161,000 | +63.3% | 204,476 | 0.0% | 0.02% | +29.4% |
| Q3 2014 | $1,323,000 | – | 204,476 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |